Global Hematology Market Overview:
The high incidence of blood and blood-related disorders leading to the usage of hematology and emergence of high throughput hematology analyzer is driving the Global Hematology market. Approximately one person is diagnosed with blood cancer every 3 minutes in the United States. Hematology is a branch of medicine which involves the study of blood in health and diseases. The disorders include Anemia, Malaria, Thalassemia, Myelodysplastic syndrome, etc. Along with this, the increasing incidence of kidney diseases is also expected to induce huge growth in the hematology market. Hematology analyzers are large automated integrated systems that combine all forms of sample processing, analysis, and presentation of results. The analyzer also helps in pre and post-analytical sample handling and management of reagent supply with limited user interference. The analyzer also helps laboratories generate results in faster turnaround time, thereby improving the efficiency and labor utilization. According to the National Hemophilia Foundation According to AMA, the Global Hematology market is expected to see growth rate of 5.0%
Market Drivers
- Increasing incidence of blood disorders and the rising rate of blood donation
- Technological advancement in hematology analyzer and reagents
- Integration of techniques like Flow Cytometry with hematology analyzer.
Market Trend
- Growing incidence of blood disorders among the population.
- Involvement of Automation in hematology instruments.
Restraints
- High cost of equipment and reagents
- Poor health insurance coverage.
Opportunities
- Availability of a large number of diagnostic centers and adoption of highly adopted hematology analyzers by the laboratories.
Challenges
- High cost of the instrument (Hematology analyzer) which is available in a portable and advanced form is making it difficult for small vendors to invest in the market.
Competitive Landscape:
The market is fragmented with many global key players who are adopting the strategy of merger and acquisition to sustain in the global hematology market. Established vendors of laboratory equipment are supplying new models of hematology analyzers at competitive prices, helping laboratories to enhance their capabilities, productivity, and workflow. They are also offering recertified instruments and reagent rental plans which is beneficial for laboratories with budget constraints.
Some of the key players profiled in the report are Sysmex (Japan), Danaher (United States), Nihon Kohden (Japan), Siemens (Germany), Abbott Laboratories (United States), Boule Diagnostics (Europe), HORIBA (Japan), Bio-Rad Laboratories (United States), Bio Systems (Europe), Diatron (Europe) and Drew Scientific (United States). Additionally, following companies can also be profiled that are part of our coverage like EKF Diagnostics (U.K.), Mindray (China), Ortho Clinical Diagnostics (United States) and Roche (Europe). Analyst at AdvanceMarketAnalytics see United States Players to retain maximum share of Global Hematology market by 2025. Considering Market by End user, the sub-segment i.e. Hospital laboratories will boost the Hematology market.
Market Highlights:
On September 2018, Sysmex launches new product for China market i.e. Hematology Analyzer XS-Series which is designed for high performance, compactness and has the ability to measure minute quantities of blood.
Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Hematology market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Hematology market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Healthcare providers, Government and regulatory bodies, Hematology Instrument manufacturers, Distributors and Suppliers, Pharmaceutical Companies and Clinics.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.